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INTRODUCTION 
The bovine respiratory disease (BRD) complex is a major cause of 
mortality and morbidity in feedlot cattle despite prophylactic 
1 2 
immunization with bacterial and viral products. ' Bovine respiratory 
disease, often r eferred to as shipping fever, is prevalent among calves 
after weaning, shipping, mixing with other calves, and placement in the 
feedlot. Factors thought to play a role in the development of BRD 
include stress (crowding, temperature extremes, transportation, airborne 
pollutants, etc.) and infectious agents, including several bacteria and 
viruses. 2 The economically important effects of BRD are usually 
associated with bacterial pneumonia, primarily by Pasteurella 
haemolytica. 3 •4 
The pathogenesis and etiology of BRD are only partially understood. 
P. haemolytica is a normal inhabitant of the upper respiratory tract of 
cattle. 4 •5 •6 During shipment or experimental viral infection, the 
numbers of P. haemolytica in the upper respiratory tract often 
dramatically increase. 4 •6 Although acute BRD is generally associated 
with pulmonary infection with P. haemolytica, efforts to reproduce 
lesions of BRD by challenge with P. haemolytica alone have met with 
. 5-11 
little success. One study showed that 90 percent of P. haemolytica 
12 experimentally instilled into the lung are cleared within 4 hours. 
During viral infection, however, pneumonia often results from 
6 13-18 
experimental P. haemolytica challenge. ' These observations have 
led to the hypothesis that multiple factors, involving the interaction of 
stressors with v irus , lead to a state of enhanced susceptibility to 
2 
bacterial infection. If host immune functions are in fact compromised by 
virus infection or stress, and since virus infection and/or conditions of 
stress often lead to large populations of P. haemolytica in the upper 
respiratory tract, it should not be surprising that calves which contract 
BRD tend to undergo bacterial pneumonia caused by P . haemolytica . The 
purpose of this report is to review the evidence that certain viruses 
associated with BRD alter host pulmonary immune defense mechanisms and to 
characterize the nature of those alterations . In addition, a genetic 
procedure which might identify subtypes of P. haemolytica in outbreaks of 
BRD is investigated. 
Explanation of thesis format 
This thesis is composed of three sections relating to 
viral-bacterial synergism in BRD. The first section is a critical review 
of bovine pulmonary immunologic defense mechanisms , the alterations of 
those mechanisms caused by viral infections, and the relationship between 
viral infection and bacterial pneumonia in the BRD complex. The second 
section is a manuscript describing research , designed and performed by 
this author (with technical assistance), concerning the functional 
alteration of polymorphonuclear leukocytes during infection of cattle 
with two respiratory viral agents. The third section is a manuscript 
describing a retrospective study, designed and performed by this author 
(with technical assistance), concerning epidemiologic aspects of the 
bacterium most frequently incriminated in severe bovine respiratory 
disease, Pasteurella haemolytica. Since stress- or virus-induced 
3 
alterations of cattle directly affect the survival and proliferation of 
P. haemolycica in both the lungs and upper respiratory passages, the 
epidemiologic aspects of P. haemolycica in bovine respiratory disease are 
intimately related to the topic of viral-bacterial synergism. A 
comprehensive literature review of all aspects of viral-bacterial 
synergism in bovine respiratory disease, however, would be exceedingly 
complex. The literature review in section 1, therefore, is limited to 
the topic of viral effects on pulmonary immunologic function . 
4 
SECTION I . VIRAL IMPAIRMENT OF IMMUNOLOGIC 
FUNCTIONS INVOLVED IN BOVINE 
RESPIRATORY DISEASE: A REVIEW 
5 
Viral impairment of immunologic functions involved 
in bovine respiratory disease: A review 
Robert E. Briggs, D.V.M. 
From the National Animal Disease Center, Agricultural Research Service, 
United States Department of Agriculture, Ames , IA 50010 
6 
INTRODUCTION 
Respiratory disease is particularly prevalent during the first 45 
days after calves have been weaned, transported, and placed in the 
1 feedlot. During this period calves encounter stressful conditions, 
nutritional changes, and exposure to a number of infectious agents from 
other co-mingled calves. There is ample evidence that stress and 
. i 1 1 . . 1 . f . 2 - 4 nutrit on p ay a ro e in immuno ogic unction. Under such conditions, 
calves would be increasingly susceptible to viral infection, whether by 
new virus in a naive calf, re-infection of a previously exposed animal, 
or recrudescence of latent viral infections. Viral infections are 
frequently incriminated in cases of severe or fatal bacterial infection 
in man and animals.s- 9 The evidence suggesting viral infection plays an 
important role in the etiology of severe bacterial pneumonia in cattle i s 
substantial.S,lO-l2 
Four viruses which have received the most attention concerning their 
involvement in the bovine respiratory disease (BRO) complex are 
infectious bovine rhinotracheitis (!BR) virus, parainfluenza -3 (PI-3) 
virus, bovine viral diarrhea (BVD) virus, and bovine respiratory 
syncytial virus (RSV). Each has been demonstrated to have effects on the 
bovine immune system, in vivo and in vitro. This report will briefly 
discuss the pulmonary immune defense mechanisms of probable relevance to 
bovine respiratory disease, review the evidence that certain viruses, 
associated with BRO, can alter pulmonary defense mechanisms, and 
characterize the nature of the alterations. 
7 
HOST PULMONARY DEFENSE MECHANISMS 
Bacteria which are deposited in the lungs may either be eliminated 
or they may multiply to result in pulmonary disease. The capacity of the 
lung to eliminate bacteria is determined by a complex and interdependent 
set of extracellular and cellular factors . Extracellular factors include 
the cough reflex, the bronchoconstriction reflex, the mucociliary 
blanket, and the alveolar milieu. Cellular factors include lymphocytes, 
pulmonary alveolar macrophages (PAM), and polymorphonuclear leukocytes 
(PMN). The mucociliary blanket physically protects underlying epithelium 
and filters many incoming particles from the airways. The ciliary action 
distal to the alveoli elevates mucus and trapped particles to be 
swallowed or expectorated. The alveolar milieu, and to some extent 
airway secretions, contain such soluble components as surfactant, 
antibody of IgA, IgG, and IgM isotypes, bacteriostatic iron-containing 
d 1 d f .b . 13-16 compoun s, comp ement components, an i ronectin . An important 
role of several components is related to agglutination of particles and 
to augmentation of phagocytic function by opsonizing particles. 
Bactericidal and bacteriostatic activity may occur by action of certain 
extracellular components without additional cellular activity. 
Bacteria which descend into the alveolus are rapidly engulfed by 
17 normal phagocytic cells of the lungs. It is felt that bactericidal 
mechanisms within the lung are more important than mucociliary transport 
in removal of pathogenic bacteria . This conclusion is based on the 
observations that the rate of bacterial killing wit hin the healthy lung 
greatly exceeds the rate of mucociliary transport out of the lungs, and 
8 
that the period of increased susceptibility to bacterial pneumonia does 
not coincide with the time of maximal inhibition of mucociliary clearance 
d . i 1 . f . 18 uring v ra in ection. The consensus of opinion seems to be that 
suppression of cellular defenses in the lungs, and suppression of systems 
which augment those defenses, is a primary factor in predisposing to 
bacterial infection. 
The first line of cellular defense in the lung is the pulmonary 
alveolar macrophage . This cell, a specialized me mber of the mononuclear 
phagocyte system, is normally capable of a number of important immune 
f . 19 unctions. The PAM p e rforms non-specific defense by the same processes 
as are performed by the PMN. These processes include adhe rence, 
chemotaxis , phagocytosis, metabolic burst, killing, and enzymatic 
degradation of ingested material . The PAM, as well as PMN and certain 
lymphocyte types, also can perform antibody-dependent 
cellular-cytotoxicity (ADCC) in which large, nonphagocytosable , targets 
are destroyed. 
In addition to its direct immunologic functions, there is evidence 
that the PAM has a central role in the overall pulmonary immune r e sponse. 
The PAM secretes soluble immunoregulatory molecules, processes antigens , 
20-23 
and presents antigens to lymphocytes . Certain lymphocytes, in 
response to PAM and antigen stimulation, secrete lymphokines capable of 
nh . PAM . . 24 • 25 Th nh f e ancing activity . e e ancement is non-speci ic and boosts 
PAM metabolic activity , phagocytosis , killing, and ADCC . Although the 
PAM has the capacity to perform many important immune functions, only 
non-specific mechanisms play important role s early in the course of 
9 
initial infectious exposure. Several days may be required for the 
induction of antigen specific defense, and lymphokine-mediated 
enhancement of macrophage function. 
Often in concert with the alveolar macrophage, lymphocytes play an 
important role in pulmonary defense by producing specific antibodies and 
19 
by augmenting the cellular immune response. Lymphocytes are found in 
both pulmonary interstitial structures and in the alveolar lumen.
16
•
26
•
27 
Lymphocyte traffic to and from the bovine lung has not been demonstrated , 
but movement to alveolar structures from blood, bronchus associated 
1 h "d t• d · 1 1 h nodes i·s li·kely.
28 •29 ymp oi issue, an regiona ymp The subtypes 
of lymphocytes obtained from human alveolar structures are similar to 
those found in blood. For T lymphocytes, populations consistent with 
h 1 d . b h b •ct . f. d 16,30-32 e per, suppressor, an cytotoxic su types ave een i enti ie . 
For B lymphocytes, surface immunoglobulins of IgM, IgD, IgG, and IgA have 
been identifiect. 16 There is evidence that lung lymphocytes function in a 
manner similar to blood lymphocytes . Lung lymphocytes respond to 
mitogens and antigens and in the mixed 
. 16 20 33 
lymphocyte reaction. ' ' 
Human lung lymphocytes also produce lymphokines when activated, which 
include macrophage migration inhibition factor, leukocyte inhibition 
factor, interleukin-2, interferon, and monocyte chemotactic 
f t 16,34-36 ac or. 
Soon after pulmonary exposure to P. haemolytica, there are 
impressive influxes of PMN into the lung, which may bolster the lungs' 
innate defense mechanisms.
37
•38 Polymorphonuclear leukocytes originate 
in the bone marrow, and are released into peripheral blood circulation. 
10 
Under appropriate circumstances, chemotactic substances are generated or 
released from host cells and/or infectious agents . The substances 
diffuse to form a gradient along which PMN orient and move.
39 
It is by 
this process that peripheral blood PMN quickly migrate into pulmonary 
tissue early in the course of pulmonic infection. Upon making contact 
with an appropriate target surface, the PMN may initiate phagocytosis or 
ADCC, depending on the size of the target. Efficiently recognized target 
surfaces are coated with opsonins, substances which promote phagocytosis. 
Important opsonins include certain subclasses of antibody, certain 
complement fragments , and perhaps fibronectin fragments and pulmonary 
40-42 surfactant. Contact with the opsonin-target complex triggers a 
chain of events in the PMN (or PAM) which l eads to internalization of the 
target particle, or to ADCC. Once internalized, the particles are 
located within phagosomes. Potent mixtures of degradative and 
bactericidal enzymes and substances are released into the phagosomes from 
43 
3 types of granules in which the substances are stored. This process 
occurs by movement of the granules into the vicinity of the phagosome and 
subsequent fusion of their respective membranes, and is known as 
phagosome-lysosome fusion . The process of migration, phagocytosis, and 
phagosome-lysosome fusion require normal cytoskeletal function, which 
implies the necessity of normal microfilament and microtubule 
. 44 45 
function. ' 
Greatly enhancing the bactericidal activity of the PMN (and PAM) is 
the oxidative burst which is stimulated following phagocytosis (in fact 
stimulated by many nonphagocytosable substances as well) . During the 
11 
respiratory burst, oxygen consumption is sharply increased with 
associated production of hydrogen peroxide and related oxygen compounds. 
The respiratory processes occur close to the membranes enclosing the 
46 phagolysosome. Many of the products produced are short lived, highly 
45 47 reactive, and very toxic both to the host and to infectious agents. ' 
From the foregoing discussion it is evident that a great number of 
mechanisms play a role in defending the lung against invading 
microorganisms. Initially, only non-specific mechanisms are available 
(which handle most of the organisms likely to invade the lung). After a 
period of days, specific mechanisms provided by involvement of 
lymphocytes supplant the non-specific mechanisms and greatly enhance 
potential antimicrobial defense . There are a number of possible ways, 
however, to impair at least some of the host defense mechanisms. A great 
deal of evidence suggests that stress or viral factors play a role in 
suppression of host defense and enhanced susceptibility to bacterial 
pneumonia. 
12 
HISTORY OF THE CONCEPT OF VIRAL-BACTERIAL SYNERGISM 
The concept of viral-bacterial synergism dates back to the 19th 
century when influenza pandemics led to great numbers of human 
fatalities. 7 It was noted that mortality during influenza epidemics is 
associated with complicating bacterial pneumonia. In the 1960s, as many 
as 50% of the pneumonia cases in humans were found to be associated with 
id f . 1 . f . 
8 
ev ence o vira in ection. Bacterial colonization of nasal passages 
was also correlated with viral upper respiratory tract infection in human 
. f 48 in ants. Non-respiratory related cases of viral-bacterial synergism 
are abundant in the literature. The most prominent example of this 
currently is the acquired immunodeficiency syndrome (AIDS) in humans. 
Human immunodeficiency virus (HIV), formerly called human T 
cell-lymphotropic virus type III, directly affects a subset of T 
lymphocytes and results in marked susceptibility to many opportunistic 
infectious agents.
6 
Parvovirus of cats or dogs often results in 
. 49 50 lymphopenia and suppressed immunity. ' In mink, parvovirus can result 
. Al . d" h" h f dl ff h 1 · . 49 M in eutian isease, w ic pro oun y a ects umora immunity. any 
other viruses, including measles, canine distemper, cytomegalovirus, 
Epstein-Barr, and infectious bursal agent can affect the immune function 
. 51-63 
of humans or animals. With evidence that many viruses have 
potential of disrupting normal immune functions, it is natural that some 
interest be directed at cattle and BRD . 
13 
EXPERIMENTAL EVIDENCE OF VIRAL-INDUCED IMMUNOLOGIC EFFECTS 
Viral infection may result in enhanced susceptibility to bacterial 
disease by a number of possible mechanisms. The direct physical effect 
of complete or abortive viral replication can damage physical barriers 
such as the mucociliary blanket. Surface structures of airways may be 
altered to permit enhanced bacterial attachment and possible 
colonization. Constituents of mucus or alveolar fluid may be altered to 
allow more rapid bacterial replication or impeded migration of host 
phagocytic cells, as may occur in pulmonary edema. Macrophages or 
lymphocytes may become infected with the virus and undergo functional 
impairment or destruction. Only selected subsets of immune cells may be 
affected, as is the case with HIV which affects T lymphocytes responsible 
for delayed-type hypersensitiv ity and provis ion of helpe r functions for 
6 other T cell responses . 
In addition to direct viral effects, alterations of immune function 
may secondarily result from the activity of soluble or particulate 
factors of viral or host origin. Many viruses result in fever, malaise, 
tachypnea, elevated plasma cortisol, and interferon production. Plasma 
. 11 64 cortisol has effects on both humoral and cell-mediated immunity. ' 
Interferon has been shown to affect chemotaxis, superoxide anion 
production , and cytotoxicity of neutrophils, as we ll as l ectin- induced 
65-67 
lymphocyte proliferation in the bovine system. Immune complexes 
have been shown to inhibit a number of phagocytic cell functions, pe rhaps 
b h t . th 11 , f . 1 b·1· . 68 y ex aus ing ose ce s unct1ona capa i it1es . These secondary 
effects often are observed slightly after peak titers of virus occur in 
14 
the host . Further research of virus-host interaction may uncover other 
common themes of immunologic alteration. 
15 
EVIDENCE OF VIRAL-BACTERIAL SYNERGISM IN BOVINE RESPIRATORY DISEASE 
Following infection with endemic viruses such as PI-3 virus and IBR 
virus , some cattle experience inapparent infection, others develop mild 
symptoms and recover, and still others develop severe disease and do not 
69- 77 survive. The outcome of viral infection apparently involves many 
factors, the definition of which are largely speculative. There is ample 
evidence that severe forms of respiratory disease observed in the field 
12,71,78-80 
result only when bacterial pneumonia is present. Experimental 
infection with PI-3 virus, IBR virus, bovine RSV, or BVD virus do not 
generally l ead to severe respiratory disease unless a bacterial agent is 
also involved.
69 
The lesions of shipping fever pneumonia are described 
in terms of bacterial involvement.
10
•
79 
Yet, numerous attempts to 
reproduce shipping fever with bacterial agents alone have met with very 
1 . . d 78,81-86 imite success. These observations give support to the shipping 
fever equation, proposed by Hoerlein in 1964, which suggests that 
pneumonic pasteurellosis results from a combination of stress, viral 
. f . d b . 87 in ection an acteria. 
The equation makes particular sense in consideration of the anatomy 
of the bovine respiratory tract and observations of bacterial nasal 
flora. Cattle suffer respiratory viral infections much more commonly 
during or shortly after shipment into the feedlot. During this same 
period, Pasteurella haemolytica can often be isolated in high 
t ti f . . 12 s. p concen ra on rom upper respiratory tract secretions . ince . 
haemolytica can be demonstrated in inspired tracheal air of animals 
harbori·ng thes r i· · th · · t t t 88 •89 the e o gan srns in eir upper respira ory rac , 
16 
lungs of shipped calves are doubtlessly exposed to higher numbers of 
potentially pathogenic organisms during and after shipment. The missing 
factor in the equation is how the Pasteurellae colonize the lung once 
they get there . It is assumed that a combination of stress and viral 
infection leads to reduced immunologic functions of the lung, and the 
bacteria which shower down from the upper respiratory tract can more 
easily colonize . There is a great deal of research currently being done 
to elucidate the mechanisms of the putative viral-induced immunologic 
deficits involved in bovine respiratory disease. 
17 
EFFECTS OF SPECIFIC VIRAL INFECTIONS IN CATTLE 
Infectious bovine rhinotrache itis virus 
Infectious bovine rhinotracheitis, caused by bovine herpesvirus 1, 
was first described by Miller in 1955 as a respiratory disease of feedlot 
69 cattle. It was soon found that IBR v irus could cause a wide variety of 
c linical manifestations other than those of t he respiratory system, 
including reproductive, ocular, alimentary, and encephalitic symptoms.
69 
This virus can result in rat h er i mpressive respiratory symptoms and 
pathologic lesions without synergistic infection wi th bacterial agents. 
Of t he known viral agents invo l ved in BRD, IBR virus shows the most 
promise of reproducing lesions and symptoms of shipping fever under 
l aboratory conditions. Aerosol exposure to IBR virus will, in many 
cases, facilitate infection of t he lung by an otherwise ineffective 
challenge with P. haemolytica, resulting in lesions and symptoms similar 
f . ld f h . . f 5 '90- 94 to i e cases o s ipping ever. Evidence is accumulating t hat 
this enh anced s usceptibili ty might be due, at least in part, to host 
immunosuppression by IBR virus. 
Infection with IBR v irus results in extensive loss of tracheal 
epi t h e lium r esulting in a reduction in t h e efficacy of the mucociliary 
95 96 
defense system. ' There are variable amounts of cellular debris and 
exudate which accumulate in the upper airways, and which may be inhaled 
and facilitate deve lopment of pnewnonia. 69 Infectious bovine 
rhinotracheitis virus e lic i ts a rapid rise in nasal interferon l evels and 
. 1 . . . f 1 1 65' 97 a margina rise in serwn inter eron eve s. There often is a 
reduction in peripheral blood l eukocyte counts accompanying infection, 
18 
though secondary bacterial infection may quickly reverse that 
. . 5,98 situation. 
Infectious bovine rhinotracheitis virus can replicate in the bovine 
PAM 
. . 99,100 
in vitro. This infection results in impairment of immune 
receptor functions as well as ADCC activity of the PAM.lOl Efforts to 
reproduce these results in vivo with PAMs lavaged from infected animals , 
102 
however, show that only a small proportion of PAMs become infected. 
Their functional activity was not measurably altered in those studies. 
Later studies provided evidence that PAMs, lavaged from !BR 
virus-infected calves, may become activated subsequent to viral 
103 challenge. These activated macrophages exhibited higher levels of 
Fe-mediated phagocytosis, higher levels of certain enzyme activities, and 
greater levels of prostaglandin E
2 
production. Cellular cytotoxicity, 
interleukin-1 production, and chemotactic factor release were each 
reduced. 
Peripheral blood lymphocytes from !BR virus-infected calves exhibit 
transiently depressed natural cytotoxicity against a xenogeneic cell line 
(YAC-1), but not against !BR virus-infected bovine fibroblasts.
65 
The 
level of natural cytotoxicity against YAC-1 parallels the periphera l 
blood monocyte counts, which is evidence that population shifts may 
account for alterations of activity. Lymphocyte responses to the 
mitogens phytohemagglutinin and concanavalin A are also depressed during 
!BR . . f . 65,104 virus in ection. The mechanism of this depression is not 
clear, but apparently other factors along with plasma interferon levels 
or viral induction of suppressor cell activity are involved. 
19 
Peripheral blood PMN from !BR virus-infected calves show reduced 
random migration and reduced directed migration toward a chemotactic 
. 1 65,98,105 st1mu us. There is evidence of an increase in phagocytic 
activity directed toward opsonized particles, and there may be a 
transient enhancement of oxidative metabolism as well.
65
•
98 
Each of the 
alterations of PMN function observed during !BR virus infection has also 
occurred following in vivo exposure of cattle to bovine gamma interferon, 
which has been shown to activate bovine PMN (Roth JA, Iowa State 
University , Ames, Iowa : Personal communication, 1988). It is possible, 
then, that although PMN might be slow to emigrate into the infected 
alveolar lumen, they are activated and possess enhanced bactericidal 
activity. 
Parainfluenza-3 virus 
Bovine PI-3 virus was originally isolated from cattle with shipping 
106 fever, and reported by Reisinger et al. in 1959 . This virus is 
ubiquitous in much of the world, and most uncomplicated natural 
infections are mild or asymptomatic. 69 Colostrum deprived or otherwise 
seronegative calves often develop mild or moderate symptoms of 
respiratory disease following experimental exposure to PI-3 
virus.
69
•
77
•
107 
Isolation of PI-3 virus from cattle with respiratory 
disease is common. 69 •77 •108 Infection with PI-3 virus has been shown to 
predispose calves to more severe respiratory symptoms upon subsequent 
exposure to P. haemolytica73 ; a later study did not confirm that 
f . d. 109 in 1ng. Impaired clearance of P. haemolytica has been reported 
20 
3 i . f . llO b h . t• t h f i.·1 d t following PI- v rus in ecti.on , ut ot er i.nves i.ga ors ave a e o 
111 112 duplicate that observation. ' While it's presence in BRD cannot be 
denied, many investigators currently are not convinced that PI-3 virus 
plays a large role. 
Parainfluenza-3 virus is capable of replicating in bovine PAMs in 
vitro. 99 This infection has been shown to inhibit glass adherence, 
phagosome-lysosome fusion, Fe mediated phagocytosis, and cytotoxic 
.. t 113, 114 acti.vi. y. Depression of in vitro lymphocyte responses to the 
mitogen phytohemagglutinin has been demonstrated following PI-3 virus 
. f . f 1 115 in ecti.on o caves. It is also reported that oxidative and 
myeloperoxidase activity of peripheral blood PMN is reduced in PI-3 virus 
infected-calves. 98 
Bovine viral diarrhea virus 
Bovine viral diarrhea was first described by Olafson et al. in 1946 
as an acute and often fatal gastro-intestinal disease similar to 
. d 116 ri.n erpest . Other cases were concurrently described which were called 
1 d . 117 mucosa isease. Some time later it was concluded that both syndromes 
were attributable to the same virus. A number of strains of BVD virus 
have been identified which vary antigenically and differ in cell culture 
cytopathogenicity, the latter characteristic giving rise to the 
. 118 119 
categorization of strains as cytopathogenic and noncytopathogeni.c. ' 
Cross neutralization occurs to only a limited extent between viral 
strains. 120 Depending on the strain of virus and time of exposure, a 
broad spectrum of clinical syndromes are possible in cattle, ranging from 
21 
mild or asymptomatic to severe. The gastro-intestinal, respiratory, 
lymphatic, reproductive (developing fetus), and integumentary systems are 
affected by BVD virus. 69 •121 Classically, mucosal disease manifests 
itself as an acute, rapidly fatal disease with fever, profuse liquid 
diarrhea and buccal ulcers. Mucosal disease may sometimes be diagnosed 
as respiratory disease due to prominent signs of fever, tachypnea, and 
69 
nasal discharge with minimal signs of diarrhea and mucosal lesions. 
The virus has an affinity for lymphocytes and rapidly dividing cells.
69 
This often results in leukopenia, and necrotizing effects on lymph nodes 
69 
and Peyer's patches. 
Probably due to limited cross-neutralization between strains of BVD 
i 119,120 d h h f i BVD . . f . 122 v rus , an t e p enomenon o pers stent virus in ection 
re-infection or superinfection with multiple strains of BVD virus is 
ibl 
123-126 
poss e . Experimental evidence suggests that the variability of 
clinical syndromes attributable to BVD virus may be due to 
im.munopathologic interactions by the host to the two or more strains of 
BVD i . h . f d . 1 126 v rus present in t e superin ecte anima . Study of this virus 
thus involves not only primary infections in naive animals with various 
strains of BVD virus, but also infections with various strains in 
persistently infected animals, or in animals previously exposed to other 
strains. 
Experimental exposure (to cytopathogenic, noncytopathogenic, or 
modified live vaccinal strains of BVD virus) of animals naive to BVD 
virus results in acute infection with few clinical signs, and a brief 
febrile response. If no complications by secondary infection occur, 
22 
recovery is rapid with accompanying rise in neutralizing antibody 
. 69,123,127-129 E . l · b f 11 titer. xposure in utero resu ts in a nwn er o we 
docwnented developmental abnormalities, including repeat breeding, 
69 130 131 
abortion, stillbirth, and weak calves. ' ' Fetuses exposed to 
noncytopathogenic BVD virus prior to approximately day 125 of gestation 
may become persistently infected, becoming immuno-tolerant to that strain 
of BVD virus and persistent ly viremic (often without obvious untoward 
ff ) 
129 ,131,132 
e ects . Persistent BVD virus infection is a considerable 
liability even in otherwise clinically normal calves. Whereas naive 
calves are relatively refractory to cytopathogenic BVD virus exposure, 
calves which are persistently infected can develop mucosal disease upon 
. h . . f BVD . 123, 124, 131 exposure to an appropriate cytopat ogenic strain o virus. 
Superinfection with a given combination of cytopathic and noncytopathic 
BVD virus does not necessarily produce overt disease in persistently 
infected animals, however , and may result in neutralizing antibodies 
. 126 131 133 specific for the cytopathic strain. ' ' Only appropriate 
combinations of cytopathic and noncytopathic BVD virus are capable of 
reproducing symptoms of mucosal disease in t he laboratory (Bolin SR, 
National Animal Disease Center, Ames, Iowa: Personal communication, 
1987). 
In contrast to the acute BVD-mucosal disease syndrome, chronic BVD 
is characterized by an insidious onset and lesser severity. 69 •130 •131 •134 
Noncytopathic BVD virus is isolated from catt l e which die from chronic 
BVD, as it is from cattle which succwnb to mucosal 
d . 123- 125 ,134 -136 isease. It is possible, therefore, t hat a similar 
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pathogenetic mechanism exists between mucosal disease and chronic BVD, 
and that severity of the disease may depend on particular immunologic 
relationships between the host and the combination of BVD virus 
. 126 
strains. 
It has been reported that dexamethasone can result in high 
susceptibility to severe disease by BVD virus, presumably by 
immunosuppression. 137 Attempts to reproduce this effect indicate that 
BVD virus acts in concert with dexamethasone, and that another disease 
agent, such as coccidia, may be involved in production of symptoms (Bolin 
SR, National Animal Disease Center, Alnes, Iowa: Personal communication, 
1987). Cattle given ACTH (which increases serum cortisol levels) along 
with modified-live BVD virus are more severely immunosuppressed than are 
cattle given modified-live BVD virus alone. 138 
In the field, infection with BVD virus commonly results in mild or 
129 inapparent symptoms. It has been reported that BVD virus is the most 
common viral agent isolated from pneumonic lungs of cattle suffering 
139 shipping fever in the Texas Panhandle. In that study most 
seroconversions to BVD virus were associated with seroconversion to P. 
haemolytica serotype 1. The predominant pathologic lesion was severe 
fibrinous pneumonia, in which cases only BVD virus and P. haemolytica 
were isolated. There were few lesions characteristic of BVD-mucosal 
disease. 
Infection of otherwise normal cattle with cytopathogenic BVD virus 
results in a reduction in peripheral blood neutrophils and T 
127 128 
lymphocytes. ' During this period a bacteremia can be detected in 
24 
. 1 140 most anima s. There is a suppression of plasma cell development and 
immunoglobulin synthesis by splenic lymphoid cells infected with BVD 
virus in vitro. 141 Infection of cattle with cytopathogenic BVD virus, or 
a modified live vaccinal strain, reduces lymphocyte blastogenic responses 
k d 
. 141 
to po ewee mitogen a mixed B and T cell mitogen, and to 
h h 1 i . a T cell . 138,142 p yto emagg ut nin, mitogen. Cattle persistently 
143 
infected with BVD virus also exhibit reduced lymphocyte activity. 
There is evidence that a low molecular weight soluble mediator may be 
responsible for some of the effects of BVD virus on lymphocyte function. 
Bovine fetal lung cells infected with BVD virus in vitro elaborate a 
substance which inhibits bovine lymphocyte mitogenesis by concanavalin 
A.
144 
Indomethacin, a cyclooxygenase pathway inhibitor, inhibits the 
elaboration of the suppressive factor(s). This provides some evidence 
that prostaglandins may be involved. In vitro infection of bovine 
monocytes with cytopathogenic or noncytopathogenic strains of BVD virus 
have also been shown to inhibit monocyte random and directed 
. . 145 migration. 
Peripheral blood PMN from cattle experimentally infected with 
cytopathogenic or noncytopathogenic BVD virus exhibit reduced 
myeloperoxidase-hydrogen peroxide-halide activity. 127 This effect occurs 
without significant impairment of overall oxidative activity (measured by 
nitroblue tetrazolium reduction or native chemiluminescence) or 
phagocytic activity (measured by paraffin oil uptake). Serum levels of 
myeloperoxidase, however, are greater in BVD virus-infected cattle, 
indicating that degranulation may be enhanced during infection, and that 
25 
reduced levels of PMN myeloperoxidase-hydrogen peroxide-halide activity 
1 f d 1 
. 146 
may resu t rom enzyme ep etion. Vaccination of cattle with a 
modified live vaccine strain of BVD virus has also been shown to inhibit 
both myeloperoxidase-hydrogen peroxide-halide activity and ADCC, but has 
no significant effect on phagocytic activity (measured by S. aureus 
138 
uptake). Neutrophils of cattle persistently infected with BVD virus, 
on the other hand, demonstrate reduced phagocytic activity (measured by 
S. aureus uptake) without evidence of impaired myeloperoxidase-hydrogen 
peroxide-halide or ADCC activity.
143 
Depressed lymphocyte blastogenic 
response to phytohemagglutinin, depressed PMN iodination, and enhanced S. 
a ureus ingestion by PMNs has bee n d emonstrated in a bull with symptoms of 
chronic BVD.
134 
Although the reduction in lymphocyte responsiveness is 
consistent with persistent BVD virus infection , the PMN functional 
capacities differ from those no ted in both acute and persistently 
infected cattle. 
Bovine respiratory syncytial virus 
Isolation of bovine RSV was reported in 1970 from cattle undergoing 
respiratory disease in Switzerland.
147 
Soon thereafter, the virus was 
isolated from BRD outbreaks in Japan a nd t h e United States. 148 - 150 The 
virus is distinct from, but antigenically related to, human respiratory 
syncytial virus, a major cause of bronchiolitis and pneumonia in infants 
d h · 1d 151 an young c 1 ren. Some cases of pneumonia caused by bovine RSV may 
1 f h . . . . 152 resu t rom a ypersens1t1v1ty reaction. In these cases, re-infection 
or persistent infection may result in symptoms of atypical interstitial 
26 
pneumonia. Infection of cattle with bovine RSV is common, as indicated 
f 1 h "b d . 151 by the high percentage o catt e wit serum anti o y titers. Under 
natural conditions, the severity of an infection may range from 
asymptomatic to fatal. Secondary bacterial infections are common in 
cattle and experimental bovine RSV infection has been shown to act 
1 f . . 1 b 153, 154 synergistically with P. haemo ytica in ection in am s. 
Scanning electron microscopy has demonstrated that ciliated 
respiratory epithelium is severely damaged after experimental infection 
with bovine RSv.
151 
Experimental infection of calves results in severe 
151 
damage to ciliated tracheal epithelium. A small number of PAMs become 
. f d b b . RSV . . 99 in ecte y ovine in vitro. It has been shown that such in vitro 
infections with bovine RSV may not affect phagocytosis of latex beads, 
but do result in impaired Fe-receptor-mediated phagocytosis of 
antibody-coated sheep red blood cells (in spite of normal Fe - receptor 
function indicated by rosetting of SRBC), and increased levels of PAM 
lysosomal enzyme activity (measured by intracellular acid 
155 
phosphatase.) Pulmonary alveolar macrophages lavaged from calves 
experimentally infected with bovine RSV, however, exhibit enhanced 
156 
ingestion of latex beads. Human RSV infection in vitro has been shown 
to be associated with impaired lymphocyte funct ion.
157 
Other viruses 
Adenoviruses, enteroviruses, rhinoviruses, and others have been 
isolated from cases of BRD. There are apparently no reports concerning 
their effects on immunologic function in cattle. 
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SUMMARY 
There is ample evidence that impairment of host pulmonary defense 
mechanisms by stressors and/or viruses are prerequisite for establishment 
of bacterial pneumonia in the BRD complex. Even under conditions 
favorable to development of bacterial pneumonia, however, only selected 
organisms successfully colonize the bovine lung, notably Pasteurella 
haemolytica serotype 1. The predominance of this single bacterial 
species and serotype suggests that despite immunologic impairment, there 
remain sufficient pulmonary defenses to prevent infection by the majority 
of bacteria contained in the bovine upper respiratory passages. It is 
evident, therefore, that specific bacterial virulence factors allow 
certain bacteria to take particular advantage of host pulmonary 
immunologic impairment. Whereas the bacterial virulence factors are 
insufficient by themselves to allow pulmonary colonization, when in 
concert with stressors and/or viruses they may often prove sufficient. 
Due to the complexity of the pulmonary immune mechanisms and to the 
complexity of the infectious agents which can alter those mechanisms, it 
is difficult to assess the precise biological events and interactions 
necessary for the development of pneumonia. The importance of 
understanding these events, however, is underscored by the marginal 
efficacy of the many immunizing and chemotherapeutic agents presently 
used in efforts to prevent or to treat BRD . While managment procedures 
to reduce stress and minimize exposure to infectious agents would reduce 
the incidence of BRD, current marketing procedures of cattle do not allow 
many such measures to be implemented. Basic research into the cellular 
28 
and molecular mechanisms of virulence and immunosuppression involved in 
the BRD complex may eventually allow effective prophylaxis against the 
more serious forms of this disease. 
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ABSTRACT 
Calves were challenge-exposed in separate experiments with 
parainfluenza-3 (PI-3) virus or infectious bovine rhinotracheitis (IBR) 
virus. Blood neutrophils were assayed for functional activity every 
other day for at least three weeks by random migration, Staphylococcus 
aureus ingestion, antibody-dependent cell-mediated cytotoxicity, 
cytochrome-c reduction, iodination, and native chemiluminescence. 
Exposure to PI-3 virus resulted in a brief febrile response and no 
other clinical signs. No alterations in total or differential WBC were 
detected. Chemiluminescence and iodination activities were reduced from 
activities before exposure. 
Exposure to IBR virus resulted in mild clinical signs and a f ebrile 
response of several days' duration. Total WBC and mononuclear cell 
counts were reduced. Random migration was reduced, whereas S aureus 
ingestion was enhanced. 
We concluded that infection of calves with IBR virus and PI-3 virus 
might directly or indirectly result in alterations of neutrophil 
function. The functional alterations are apparently different for each 
virus. These virus-induced alterations in neutrophil function might 
predispose calves to secondary bacterial pneumonia. 
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INTRODUCTION 
In the bovine respiratory disease (BRD) complex, stress or viral 
infection are thought to precede bacterial pneumonia,
1 
usually caused by 
2 Pasteurella spp. Although various viruses, chlamydia, mycoplasmas, and 
bacteria have been implicated in the generation of BRD, there has been 
little success experimentally inducing the disease with any single 
3 agent. Experimentally induced infection with infectious bovine 
rhinotracheitis (IBR) virus or parainfluenza-3 (PI - 3) virus, then 
inoculation with Pasteurella haemolytica a few days later, has produced 
1 . . 1 BRD . 1 3 -G c inica in severa cases. Results of studies in animals other 
than cattle with cytomegalovirus, influenza virus, and parainfluenza 
virus indicate that viral infection can predispose to bacterial 
. f . 3,7,8 in ection. The suspected mechanisms of this viral effect vary among 
viruses and host species . McGuire and Babiuk9 found that experimental 
infection of calves with IBR virus reduced lymphocyte blastogenic 
response to phytohemagglutinin, and reduced random and directed migration 
of neutrophils in vitro. They concluded that a delay in recruitment of 
neutrophils into infected lungs might allow bacteria to colonize. The 
goal of the study reported here was to further define the alteration of 
neutrophil function after infection of cattle with IBR virus, and to 
determine whether infection with PI-3 virus might influence neutrophil 
function in cattle. 
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MATERIALS AND METHODS 
Animals 
Twelve colostrum-deprived Angus-type steer calves, approximately 1 
year old, were used. The calves were allotted to treatment and 
nonexposed groups of six each . The same groups of calves were used for 
both experiments, one with !BR virus and one with PI-3 virus . 
Hemagglutination inhibition (HI) titers to PI-3 virus before experimental 
exposure ranged from 1 : 20 to 1:40. All calves were seronegative to !BR 
virus by the serum neutralization (SN) test. Three weeks after exposure , 
viral antibody titers were measured again. 
Virus 
Each virus was grown in secondary embryonic bovine kidney cells, 
then stored at -70 C. 8 The titer of the PI-3 virus preparation was 10 
TCID I 1 T. f h !BR . . 105 ·8 d 108 SO m . iters o t e virus preparations were an 
TCID
50
/ml for first and second exposures, respectively. 
Exposure 
The PI - 3 virus was aerosolized by use of 2 nebulizers (3 um 
3 
droplets, each aerosolizing 0.1 ml/min, DeVilbiss) into a 1 m chamber, 
from which each calf breathed for 15 minutes via a face mask. Three 
months later, the experiment was repeated with !BR virus. Two ml of !BR 
2 virus suspension was sprayed from an air-powered atomizer (352 g/ cm ) 
into each nostril of each calf in the experimental group. Because of 
only mild febrile responses and clinical signs, the calves were 
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re-exposed to IBR virus 4 days after the initial exposure. To evaluate 
clinical effect of infection, rectal temperatures were taken daily and 
clinical signs were subjectively assessed every other day. Blood was 
collected every other day into an EDTA-containing tube for total and 
differential WBC counts. 
Neutrophil isolation 
In each experiment, blood was collected every other day for one week 
prior to exposure and for at least two weeks after exposure. From each 
calf, 250 ml of blood was drawn into centrifuge bottles containing 30 ml 
of double strength acid-citrate-dextrose solution. Neutrophils were 
isolated by hypotonic lysis, as previously described.lo Briefly , serum, 
huffy coat, and a liberal portion of the packed cell layer were removed 
by aspiration. Erythrocyte s in the remaining packed cell layer (about 50 
ml) were treated twice with lysis by addition of 2 volumes of 
phosphate-buffered water (0.0132M), then 45 seconds later by addition of 
1 volume of triple strength phosphate buffered saline solution (2.7% 
saline, 0 . 0132M phosphate). After a final wash in phosphate buffe red 
7 saline (0.0132M, PBS), the cells were resuspended at 5 x 10 /ml in PBS. 
Purity was assesse d by differential counting of the neutrophil 
preparation. 
Neutrophil function assays 
Evaluation of random migration under agarose, Staphylococcus aureus 
ingestion, antibody-dependent cell-mediated cytotoxici ty (ADCC), 
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cytochrome-c reduction, iodination, and native chemiluminescence were 
. . 10-12 done essentially as described by others. All test samples were 
incubated at 39 C. Cytochrome-c reduction was done in triplicate and 
included control wells without neutrophils . The ADCC assay was done in 
quadruplicate and included control wells without neutrophils. Native 
chemiluminescence was not replicated, but included a nonstimulated 
control sample (without opsonized zymosan) for each neutrophil sample. 
All other assays were run in duplicate. Staphylococcus aureus ingestion 
and iodination included control tubes without neutrophils for total and 
background radioactivity determinations. 
Statistical analysis 
The da ta were split into two periods, a control period from 1 week 
b efore exposure through 2 days after exposure, and a period of infection 
from 4 through 11 days after exposure. Postexposure day 2 was included 
in the control period because there was little evidence of clinical 
disease at that time, and no effect on neutrophil function was evident. 
Exposed calves were cons idered to be in the viral incubation stage. No 
differences between exposed and nonexposed groups were evident 2 weeks or 
more after exposure. An analysis of variance procedure was used to 
account for overall differences between control and treatment groups, 
calves within each group, and date of sampling. Treatment effect was 
judged from the treatment group by time interaction. The error term was 
residual variation of calf within group within day of sampling . 
Conservative degrees of freedom were used (1 for each calf rather than 1 
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for each blood sample evaluated) in an F-test to determine significant 
treatment effect. Sufficient divergence of t he virus exposed group from 
the control group, after virus exposure, thus would indicate a 
significant treatment effect. This statistical model would account for 
the effects of possible preexisting differences in neutrophil activity 
between groups and between calves within groups. 
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RESULTS 
Clinical response to infection 
Five of 6 calves exposed to PI-3 virus were febrile (rectal 
temperature> 39.4 C), 3 of which were febrile for 3 or more days (Fig 
1). All 6 cal ves were febrile by 5 days after exposure to IBR virus (Fig 
1). Five of these calves remained febrile for 8 or more days. Calves 
had other mild clinical signs of disease including tachypnea, swelling 
and reddening of nasal mucosa, and moderate mucoid nasal discharge. 
Postexposure HI titers to PI-3 virus ranged from 1:160 to~ 1:640 in the 
exposed group . Postexposure SN titers to IBR virus were ~ 1:256 in the 
exposed group (except in one calf that had a titer of 1:128). Calves in 
the nonexposed group remained healthy and had no increases in viral 
antibody titer to IBR virus or to PI-3 virus. 
Blood leukocyte counts 
Mean blood leukocyte counts for control calves during each 
13 experiment were within an accepted normal range (Table 1). Total and 
differential counts of PI-3 virus - exposed calves did not change 
significantly after exposure and remained within an accepted normal 
range
13 
(Fig 2). Total WBC count and mononuclear cell count decreased 
significantly (f<0.02) in the IBR virus-exposed calves after exposure , 
13 although leukocyte counts remained within an acceptable normal range 
(Fig 3). 
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Neutrophil preparation purity 
Neutrophil preparations had a mean > 90% of polymorphonuclear 
neutrophils (range, 75 to 99%). The samples with less purity were 
associated with less cell yield, and greater numbers of contaminating 
mononuclear cells. A few samples contained up to 18% eosinophils. An 
analysis of variance procedure was used to determine whether the 
variation of eosinophil, mononuclear cell, or neutrophil percentages were 
correlated with measurable functional differences . No significant 
association was found at these degrees of contamination. 
Neutrophil function factors 
Mean values of neutrophil function factors for control calves during 
each experiment were used to establish baseline values for each factor 
(Table 1). Exposure to PI-3 virus caused no significant change in random 
migration, S aureus ingestion, cytochrome-c reduction, or ADCC. However, 
both chemiluminescence and iodination were reduced (f<0.02) from amounts 
before infection (Fig 4) . Infection with IBR virus caused no significant 
change in cytochrome-c reduction, ADCC, chemiluminescence, or iodination. 
However, random migration was reduced (f<0.02) and S aureus ingestion was 
enhanced (f<0 . 01) from amounts before infection (Fig 5). 
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FIGURE 1. Mean rectal temperature for exposed calves after exposure to 
infectious bovine rhinotracheitis virus or parainfluenza-3 
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FIGURE 2. Total WBC and mononuclear cell counts before and after 
exposure to parainfluenza-3 virus 
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FIGURE 3 . Total WBC and mononuclear cell counts be fore and after 
exposure to infecti ous bovine rhi notracheitis virus 
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TABLE 1. Mean values for neutrophil function factors and WBC count for 
control calves (n=6) during experiments with infectious bovine 
rhinotracheitis (IBR) virus and parainfluenza-3 (PI-3) virus 
PI-3 IBR 
Factor Mean SEM Mean SEM Units 
Iodination 23.8 0. 77 42 . 0 1. 7 a 
Cytochrome-c reduction 0.40 0.01 0 . 35 0.01 00
550 
Antibody-dependent cell-
mediated cytotoxicity 93 . 4 3.0 90 . 0 4 . 0 b 
Native chemiluminescence 2263 66 2218 82 c 
~ aureus ingestion 47.9 1. 6 34.6 1.1 % ingestion 
Random migration 10.9 0 . 2 13.1 0 . 3 mm 
Total WBC count 8202 240 7850 138 cells/ mm 
3 
Mononuclear cells 6039 198 4932 ll6 cells/ mm 
3 
Neutrophils 2082 ll9 2797 ll3 cells/mm 3 
Eosinophils 81 14 121 25 cells/ mm 3 
a 7 
nmoles Nal/10 PMN/hr. 
bPercent chromium release. 
c 
Sum of 10 counts over 70 minutes in liquid scintillation counter in 
out of coincidence mode . 
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FIGURE 4 . Neutrophil functions before and after i nfection with 
parain fluenza-3 virus i nfection. Days before exposure through 
postexposur e day 2 (so l i d) and postexposure days 4 t hrough 11 
(diagonal l i nes ) are shown as percentage of control. 
Statistical significance was assesse d by use of treatment 
group by time interaction 
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FIGURE 5 . Neutrophil functions before and after infection with 
infectious bovine rhinotracheitis virus. Days before exposure 
through postexposure day 2 (solid) and postexposure days 4 
through 11 (di agonal lines) are shown as percentage of 
control . Statistical significance was assessed by use of 
treatment group by time interaction 
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DISCUSSION 
Results of our study indicate that infection with PI-3 virus or IBR 
virus can directly or indirectly alter blood neutrophil function in 
calves. Viral infection might cause immunosuppression by various 
mechanisms . Direct viral effects might be caused by the action of 
soluble or insoluble viral products, or by viral infection of immune 
cells, resulting in functional impairment or cellular destruction . 
Indirect effects migh t result from fever, high plasma cort i so l 
concentration, interferon production, i mmune complexes, immune 
hypersensitivity, or by act ivation of latent infecti ons wi t h other 
agents. In addition, there is evidence that blood neutrophils are not 
14 functionally homogeneous. A population shift might result in 
alteration of measured f uncti onal capacity. 
Parainfluenza-3 virus is ubiquitous in much of the world. Cattle in 
field situations are seldom seronegative. 15 Partly because of this, most 
uncomplicated natural infections are mild or without clinical signs . 
Immunity after vaccination or natural exposure is partial rather than 
c omplete, and it is possible to experimentally re-infect calves after 
. PI 3 . 15 prior exposure to - virus. The calves in our study had become 
seropositive to PI-3 v irus before experimenta l exposure, as evidenced by 
seronegative (SN) status at 1 month of age, and low HI titers just before 
experimental exposure. The mild fevers, minimal clinical signs, and the 
sixteen-fold rise in serum HI titers to PI-3 virus after PI-3 v i rus 
exposure were compatible with other experimental PI-3 virus re-infections 
. 16 17 
in calves . ' Despite the mild clinical course of PI-3 viral 
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infection, iodination and chemiluminescence by neutrophils were reduced 
from amounts before infection. Reduced iodination activity by 
neutrophils has been noticed also by Roth and Kaeberle
18 
in cattle given 
a modified live vaccine strain of bovine viral diarrhea virus. 
In both virus-exposure experiments, we used three measures of 
neutrophil oxidative metabolism: native chemiluminescence, cytochrome-c 
reduction, and iodination. Native chemiluminescence measures several 
oxidative reactions during the oxidative burst of the neutrophil, thus 
reflecting overall neutrophil oxidative activity. Cytochrome-c reduction 
measures superoxide anion production by the neutrophil. The iodination 
reaction depends on phagocytic activity, oxidative metabolism, 
degranulation, and the capacity of myeloperoxidase to iodinate tyrosine 
.d 10 res1 ues. Because we did not observe a change in cytochrome-c 
reduction, superoxide anion production appears normal. It has been 
reported that the chemiluminescent response depends somewhat on 
myeloperoxidase activity; hence, chemiluminescence might correlate with 
. d. . 19,20 10 1nat1on. The rate-limiting step for the iodination reaction 
appears to be associated with myeloperoxidase activity subsequent to 
10 
degranulation. The observed reductions in chemiluminescence and 
iodination subsequent to PI-3 viral infection then might have been cause d 
by a loss of myeloperoxidase activity. This loss of activity might be 
caused by direct effects on myeloperoxidase, by partial inhibition of 
degranulation, or by a reduction in amount of myeloperoxidase available 
in primary granules. Reduction of phagosome-lysosome fusion has been 
reported in PI-3 virus-infected bovine alveolar macrophages in vitro. 21 
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Ultrastructural analysis or fluorometric neutrophil function assays might 
clarify t he reason for the apparent loss of myeloperoxidase activity. In 
any case, it appears that infection with PI-3 virus directly or 
indirectly reduced one of the neutrophil's more important bactericidal 
mechanisms. 
In retrospect, the initial exposure to IBR virus was adequate. On 
the fifth day after exposure, all exposed calves were febrile. Reported 
22 
incubation periods for IBR virus range from 2 to 6 days. The initial 
IBR viral exposure in our experiment was lower than that used in our 
previous experiments. 23 Because the incubation period for IBR virus has 
been shown to be inversely related to the magnitude of viral exposure,
24 
the longer - than-expected incubation period is not unreasonable. 
Re-exposure to IBR virus 4 days after the initial exposure apparently was 
unnecessary, but probably did no harm because the calves were likely 
beginning to shed virus by this time, 25 although no virus isolation 
procedures were done in these experiments. 
It is improbable that prior exposure to PI-3 virus altered the 
effects of IBR viral infection, because effects of PI-3 virus are not 
known to be latent. However, the ubiquity of PI-3 virus in the field 
suggests that persistent infections might develop, so PI-3 virus could 
potentially exert some effect on the response of cattle to other agents. 
Also considering the ubiquity of PI-3 virus, such effects would be 
commonplace. In our experiment, we could not demonstrate functional 
alterations of neutrophils beyond 2 weeks after exposure to PI-3 virus. 
Values of infected calves returned to the baseline values of control 
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calves within 2 weeks after exposure to PI-3 virus and remained there 
until exposure to IBR virus 3 months later. 
Infection with IBR virus was associated with reduced random 
migration and enhanced S aureus ingestion, whereas neutrophil oxidative 
capacity was largely unaffected. The reduction in neutrophil random 
migration supports the observation by McGuire and Babiuk,
9 
who noticed a 
reduction i n random migration and directed migration toward a chemotactic 
stimulus . They postulated that delay of neutrophil recruitment into 
infected lungs is responsible for enhanced susceptibility to pneumonia . 
Bielefeldt Ohmann and Babiuk26 noticed a transient increase in neutrophil 
superoxide anion production from day 4 through day 12 after exposure to 
IBR virus in calves given low or moderate doses of virus. We did not 
observe a change in superoxide anion production measured by cytochrome-c 
reduction. In our experiments.the neutrophil's oxidative killing 
mechanisms appeared unimpaired, and their ability to ingest opsonized 
particles actually was enhanced in IBR virus-infected calves. The 
alterations of neutrophil function observed during IBR virus infection 
are consistent with alterations due to gamma interferon exposure. Gamma 
interferon has been shown to activate bovine neutrophils, consistently 
resulting i n reduced random and directed migration, and often resulting 
in enhanced S aureus ingestion, ADCC, and certain measures of oxidative 
metabolism (Roth JA, Iowa State University, Ames, Iowa: Personal 
communication, 1988).
27
•
28 
This suggests that if neutrophils get into 
the lungs, they should be effective at clearing bacteria, assuming that 
those bacteria are opsonized. A delay in recruitment of neutrophils to 
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lung tissue invaded by bacteria, however, might allow the bacteria to 
become established and replicate rapidly. In addition, the delay might 
allow Pasteurella haemolytica to elaborate sufficient quantities of 
. 29 30 
leukotoxin to kill the neutrophils that finally arrive. ' 
Infection with !BR virus or PI-3 virus has been shown to result in 
the proliferation of P. haemolytica in the upper respiratory tract of 
23 
calves. Pasteurella haemolytica has been isolated from droplets in 
. . d h 1 . 31, 32 inspire trac ea air. The lungs, therefore, tend to be exposed to 
greater amounts of P . haemolytica during viral infection. Normally the 
1 1 P h 1 . . dl 33, 34 ungs can c ear . aemo ytica rapi y. Virus-infected calves, 
however, are often unable to clear P. haemolytica from the lungs.
24
•
35
-
37 
Because the neutrophil is one of the predominant cells in inflamed 
38 
lungs, and influxes of neutrophils into the lungs correspond with 
1 . f h 11 b . 39 h . b li . . c earing o c a enge acteria, t ere is reason to e eve it is an 
important cell in pulmonary defense. If virus-induced defects in 
neutrophil function account for the enhanced susceptibility of calves to 
bacterial invaders, the mechanisms appear to differ between !BR virus and 
PI-3 virus. Whereas neutrophils of PI-3 virus-infected calves apparently 
6 
are recruited in normal numbers, their oxidative bactericidal activity 
might be reduced. Neutrophils of !BR virus-infected calves apparently 
9 
are recruited in less than normal numbers. Their oxidative bactericidal 
activity, however, appears to be adequate. 
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ABSTRACT 
Plasmids from 518 isolates of Pasteurella haemolytica from pneumonic 
bovine lungs and bovine nasal passages ranged in size from 2 to 7 
megadaltons. The plas mid profiles were limited in number and were 
associated with serotype. None were exclusive to lungs or to nasal 
passages. There was no association of plasmids with virulence a l though 
ampicillin resistance was found to be plas mid mediated. To assess 
whether plasmid conten t might prove useful in epidemiol ogic studi es of P. 
haemolytica, 200 cal ves were sample d during shipment to t he feedlot. 
Plasmid profiles of i so l ates obtained show t hat calves can simul taneously 
shed multiple strains of P. haemolytica, and that s he ddi ng may shi ft from 
one str a in to another over time. The smal l number of plasmid profiles 
found in P. haemolytica limits t heir value in e p idemiologi c studies. 
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INTRODUCTION 
Pasteurella haemolytica is commonly carried in the nasal passages of 
healthy cattle and sheep, and is frequently associated with pneumonia in 
b h . 1, 2 12 h b d 1, 3 '4 ot species. Over serotypes ave een recovere . Serotypes 
1 and 2 are frequently isolated from the nasal passages of healthy 
1 5 cattle. ' Serotype 1 is recovered from nasal passages with increased 
f d . . f d 1 l,S requency an in greater quantity rom stresse catt e. Isolates from 
1 
pneumonic bovine lung are primarily serotype 1. Other serotypes are 
infrequently isolated.
1 
Since bovine respiratory disease (BRD) involving P. haemolytica is 
associated primarily with isolates of serotype 1, serological surveys are 
of limited use in epidemiologic studies of P. haemolytica in BRD. A 
similar situation exists with human Salmonella and staphylococcal 
infections in which isolates of common serotype are encountered with 
common antibiotic sensitivity but with different genetic 
h . . 6, 7 c aracteristics. In these studies, rapid techniques were utilized to 
identify plasmid profiles of the organisms under study. The plasmid 
profiles differed among isolates which otherwise appeared identical and 
thus proved useful in epidemiologic consideration of those isolates. The 
objective of the present study was to utilize a rapid plasmid 
identification technique to determine the number and size of plasmids 
carried by bovine isolates of P. haemolytica , to search for plasmids 
carried by lung isolates, or associated with antibiotic resistance, and 
to examine the suitability of plasmid screening for epidemiological 
studies of P. haemolytica in BRD. 
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MATERIALS AND METHODS 
Plasmid isolation and resolution 
A series of P. haemolytica isolates from naturally occurring 
infections in cattle from several areas of the United States were 
examined for their plasmid content by a modification of the method of 
Kado and Liu. 8 Briefly, a small sample of bacteria was suspended in 40ul 
TE buffer (lOmM Tris, lmM EDTA, pH 8.0) and lysed for 30 minutes at 57C 
in lOOu l of a solution containing 3% SDS, 30mM NaOH, and lOmM Tris (pH 
12.5). The lysate was extracted with 50:50 chloroform:distilled-phenol, 
chilled on ice , and centrifuged at 12,000G for 10 minutes . The aqueous 
supernatant then could be aspirated (taking care to avoid the material at 
the interface) and loaded onto 1% agarose vertical gels. The gels were 
electrophoresed at approximately 8 volts/cm in tris-borate buffer, pH 
8.25. Molecular weight of plasmids were estimated by comparison with 
plasmids of known molecular weight. Serotypes were determined by plate 
1 . . . k . 9 agg utination against nown antisera. One hundred ten isolates of 
serotype l, 2 isolates of serotype 2, 3 isolates of serotype 6, and 2 
isolates of serotype 11 were analyzed from pneumonic lung. Three hundred 
twenty five isolates of serotype 1, 75 isolates of serotype 2, and one 
isolate of serotype 11 were analyzed from nasal passages . 
Antibiotic resistance 
One hundred and five isolates of serotype 1 were tested for 
antibiotic sensitivity by the disc diffusion technique. Antibiotics 
tested were: ampicillin, penicillin, gentamicin, neomycin, streptomycin , 
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spectinomycin, erythromycin, lincomycin, triple sul fa, and tetracycline. 
Since a high degree of correlation was noted between plasmid carriage and 
ampicillin resistance, manipulations were performed to see whether 
ampicillin resistance is plasmid mediated . Plasmid DNA was used from an 
ampicillin resistant isolate of P. haemolytica serotype 1 to transform E. 
coli K-12 strain HB101 by a calcium chloride technique.
10 
Ampicillin 
resistant colonies were selected. In order to show that P. haemolytica 
DNA had in fact been transferred, radiolabeled plasmid DNA from the donor 
P. haemolytica strain was used to hybridize with transformed and 
untransformed E. coli by a colony hybridization technique.
11 
Epidemiologic study 
For epidemiologic study, 100 calves in each of two studies were 
sampled at two or more times during shipment. In the first study, calve s 
were sampled by nasal swabs (one per nostril) upon arrival at the 
order-buyer barn, and subsequently upon arrival at the feedlot. In a 
later study, calves were sampled at the farm of origin, upon arrival at 
the order-buyer barn, upon arrival at the feedlot, and on 3 subsequent 
occasions at the feedlot. Isolation of P. haemolytica was performed on 
blood agar p lates, and serotypes were confirmed by plate agglutination. 9 
Five isolates of serotype 1 from each calf, on each day in which shedding 
was noted, were analyzed for plasmid content. 
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RESULTS 
Serotype 1 isolates displayed 3 plasmid profiles with 2 
predominating, as well as a large number of strains with no plasmids (Fig 
1). The predominant profiles (a and b) were observed in 24% and 53% of 
the serotype 1 isolates respectively . These isolates, and plasmidless 
strains (23%), were widely distributed in the United States and were 
found in both nasal passages and pneumonic lungs in approximately equal 
proportions. Profile c was obtained from a single lung isolate. The 
profiles included a total of 6 bands ranging in apparent M\.l from 2.5 to 
2.9 Mdal . Several plasmids of identical size were common to more than 1 
profile . 
Serotype 2 isolates included 3 profiles plus strains with no 
plasmids (Fig 1). One of these profiles, plus plasmidless strains, were 
found to be widely distributed in the United States. The profiles 
included 2 plasmids of 2.7 and 2.4 Mdal. 
One of the 3 serotype 6 isolates contained 3 plasmids of 3.6, 3.0, 
and 2.6 Mdal (Fig 1). The other two isolates contained no plasmids. 
Each of the 3 serotype 11 isolates contained a different profile 
with only one plasmid size shared among 2 of the isolates ( Fig 1). These 
profiles included 5 plasmids, one at 2.3 Mdal and the others ranging form 
5 . 3 to 7.1 Mdal. 
No two isolates of different serotype carried common plasmid 
profiles, although plasmidless strains are common in serotype 1 and 
present in many of the other recognized serotypes (unpublished data). 
Nasal isolates of P. haemolytica from a single herd at a given time often 
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contained varied plasmid profiles (Fig 2). 
Of 105 isolates tested for antibiotic sensitivity by the disc 
diffusion technique, 70 were resistant to ampicillin and 76 contained 
plasmids . All resistant isolates contained plasmids. 
Screening of E. coli, transformed with P. haemolytica plasmid DNA, 
on ampicillin selective media demonstrated t hat some transformants 
carried plasmids of sizes (2.5 and 2.7 Mdal) similar to the donor P . 
haemolytica strain. Other transformants were plasmidless. When the 
transformants were hybridized to radiolabeled plasmid DNA isolated from 
the P. haemolytica donor strain, strong hybridization was observed with 
the plasmid containing transformants, weak hybridization was observed 
with the plasmidless transformants, and no hybridization was observed 
with untransforme d HB101 (data not shown). 
In the first epidemiologic study, three plasmid profiles were 
identified (Table 1). It was possible to isolate P. haemolytica from 79% 
of the calves, but only 12% were identified as carriers on both dates. 
Of the 1 2 %, 4 changed from one strain to another, judged by plasmid 
content, and one calf shed 2 strains simultaneously. In eleven cases 
where shedding occurred on a single date, it was possible to recover 2 
strains of P . haemolytica on that same date. 
In the second epidemiologic study only 2 plasmid profiles were 
identified (Table 2). It was possible to recover P. haemolytica from 75% 
of the calves, of which 59% shed on 2 or more dates of sampling. Only in 
4 cases was simultaneous shedding of 2 strains noted . Only one calf 
changed from shedding one strain to another. 
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Figure 1 . Plasmid profil es obtained from bovine isolates of Pasteurella 
haemolytica serotypes 1 , 2 , 6 , and 11 . Markers correspond to 
chromosomal DNA and plasmids of known molecul ar weight (5.5 
and 2.6 Mdal) 
Chr 
5.5 
Mdal 
2.6 
Mdal 
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St-1 St-1 
Figure 2 . Typical plasmid profiles of nasal isolates of Pasteurella 
haemolytica serotypes 1 and 2 obtained from a single herd of 
cattle during shipment to the feedlot . Markers correspond to 
chromosomal DNA and plasmids of known molecular weight (5.5 
and 2 . 6 Mdal) 
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Table 1. Summary of plasmid profiles of Pasteurella haemolytica isolated 
from 100 calves sampled on 2 dates during shipment to the 
feedlot 
Plasmidless 
8% 
Isolations 
None 
Once 
Twice 
Profile a 
38% 
Calves 
21 
67 
12 
Profile b 
54% 
Mixed Profiles 
11 
1 
Changed Profiles 
aBetween dates, three calves changed from shedding isolates 
containing plasmid profile 1 to isolates containing profile 2, one calf 
changed from profile 2 to plasmidless. 
84 
Table 2. Summary of plasmid profiles of Pasteurella haemolytica isolated 
from 100 calves sampled on 6 dates during and after shipment to 
the feedlot 
Plasmidless 
0% 
Isolations 
None 
Once 
Twice 
Three 
Four 
Profile a 
Calves 
25 
16 
22 
27 
10 
82% 
Profile b 
18% 
Mixed Profiles 
2 
1 
1 
0 
Changed Profiles 
aBetween dates, one calf changed from shedding isolates containing 
plasmid profile 1 to isolates containing profile 2. 
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DISCUSSION 
The results of this study do not support a major role for 
plasmid-borne virulence factors of P. haemolytica in bovine respiratory 
disease. The frequency of recovery of a given plasmid profile from lung 
isolates was no greater than from nasal isolates. This suggests these 
plasmids offer no great selective advantage in ability to colonize lung. 
Plasmidless strains comprised 25% of the isolates recovered from 
pneumonic lung, demonstrating plasmids are not necessary for virulence. 
Zimmerman and Hirsh passed ampicillin resistance from a biotype T 
isolate of P . haemolytica to E. coli by transformation with plasmid DNA, 
but their transformed ampicillin resistant E. coli failed to demonstrate 
plasmid DNA. 12 They speculate the resistance gene may be coded on a 
transposable element. Since we were able to pass ampicillin resistance 
to E. coli with P. haemolytica plasmid DNA, it is evident that the 
ampicillin resistance gene is plasmid borne in P. haemolytica serotype 1, 
as it was in the biotype T isolate which Zimmerman and Hirsh utilized. 
Hybridization data show that P. haemolytica DNA was passed to all E. coli 
transformants, since untransformed E. coli did not hybridize while all 
transformants did. Since plasmidless transformants hybridized with 
radiolabeled P. haemolytica plasmid DNA, it is likely that the ampicillin 
resistance gene is encoded on a transposable element which incorporates 
into the E. coli genome. In contrast to the data of Zimmerman and Hirsh, 
however, we were able to recover intact plasmids from some transformants, 
demonstrating that P. haemolytica plasmids can exist in E. coli K-12 as 
independent replicons. 
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The recovery of identical plasmid profiles within a given serotype 
from widely separated parts of the United States may indicate that only a 
few plasmids can be stably maintained in a given serotype of P. 
haemolytica. It may, however, be a reflection of the wide dissemination 
of a few strains of P. haemolytica through transportation of cattle. 
Since both serotypes 1 and 2 of P. haemolytica may be isolated from a 
single herd, and since a given animal may simultaneously shed 2 strains 
of P. haemolytica serotype 1, it is evident that a good deal of mixing 
occurs among strains of P. haemolytica. If transfer of plasmids were 
possible between serotypes it would be expected that serotype would not 
be inferred by plasmid profile. The fact that plasmidless strains are 
found among many serotypes of P. haemolytica, and that plasmids of 
serotype 1 isolates do not hybridize with genomic DNA largely precludes 
the possibility that plasmids specify serotype. The obvious conclusion 
is that either P. haemoly tica transfers plasmid DNA to other P. 
haemolytica with great difficulty, or that certain strains of P. 
haemolytica are incompatible with particular plasmids. By either 
freeze-thaw techniques or calcium-chloride techniques, plasmid transfer 
from P. haemolytica serotype 1 into plasmidless strains has not been 
successful (unpublished results). The evidence therefore points to 
incompatibility of plasmids as the basis of serotype specificity of 
plasmid profiles. However, among isolates obtained from sheep (which 
commonly carry any serotype contained in biotype AP. haemolytica), a 
given plasmid profile may be found in a subset of P. haemolytica 
serotypes (except serotype 1, unpublished results). If profiles carried 
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by multiple serotypes have identical plasmids in common, it may be 
possible to develop effective protocols to transfer plasmids among a 
limited number of P. haemolytica serotypes. 
At the present time, the infectious spread of P. haemolytica in 
outbreaks of BRD is subject only to speculation. Serotyping of P. 
haemolytica isolates has shown that BRD involving P. haemolytica is 
primarily associated with serotype 1. 3 Many healthy calves carry P. 
haemolytica in low numbers in their upper respiratory tract. 3 •
4 
It is 
possible that calves undergoing viral infection or stress may develop 
pneumonia caused by their own flora. Alternatively, these same calves 
may be susceptible to P. haemolytica shed by other calves. Since several 
plasmid profiles exist in isolates of P. haemolytica, and these 
d ifferent isolates often coexist in the same herd of cattle, further 
epidemiologic studies may be possible. Evidence obtained in the present 
experiment neither supports nor disproves animal to animal spread of P. 
haemolytica, although simultaneous carriage of two strains suggests that 
superinfection might occur by environmental exposure to P. haemolytica. 
The small number of plasmid profiles carried by P. haemolytica limits 
their usefulness as epidemiologic markers. Large numbers of cattle 
sampled at frequent intervals may be required for satisfactory 
epidemiological analysis. Techniques involving in situ colony 
hybridization could make such studies possible. 
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SUMMARY AND CONCLUSIONS 
It is well known that several factors acting in combination are 
necessary to produce bacterial pneumonia in the BRD complex. The 
association of respiratory viral infection with development of bacterial 
pneumonia has led to the concept t hat viral-bacterial synergism might 
play an important role in BRD. In support of this concept is 
considerable evidence that bovine immunologic function is often altered 
or impaired by common respiratory viral agents. It is not clear, 
however, exactly which immunologic functions must change, nor how much 
change is necessary to permit bacteria to successfully colonize bovine 
lungs . The answer to these questions will likely be as complicated as 
the disease itself. Many immunologic functions lead to immunity, and 
bacteria vary in their ability to colonize bovine lungs. Effective 
preventive measures against BRD will l ikely depend upon more complete 
understanding of host-viral -bacterial interactions at the cellular and 
molecular level. 
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